Circulating Tumor Cell Market Accrues Phenomenally by 2023 with a Staggering CAGR 20.56% by Top Pivotal Players
The global circulating tumor cell market was valued at USD 9393.1 Million in 2017 and is expected to attain USD 28,399.2 Million by the end of 2023. Factors such as growing prevalence of cancer, increasing research and development activities, advances in biomedical and bioengineering technology and rise in global geriatric population are factors which will shape the global circulating tumor cell market and help it attain a CAGR of 20.32% over the forecast period of 2018-2023.
View full press release